SAN ANTONIO — Use of low-dose tamoxifen conferred a sustained reduction in risk for recurrence among women with noninvasive breast cancer, according to updated results from the randomized, phase 3 TAM ...

Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence. The findings ...

Premenopausal women with ER-positive breast cancer experienced a decreased rate of recurrence when given an aromatase inhibitor, compared with those given tamoxifen. However, more research is still ...

MammaPrint effectively predicts chemotherapy benefit and distant recurrence-free interval in HR+HER2- early breast cancer. High-risk patients benefit significantly from chemotherapy, while low-risk ...

Please provide your email address to receive an email when new articles are posted on . Patients with DCIS who received tamoxifen had a lower 15-year risk for ipsilateral breast cancer recurrence.

PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...

Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definition is lacking ...

Regular monitoring can help identify signs of thyroid cancer recurrence. Many treatment options can help treat recurrent thyroid cancer. The thyroid uses the mineral iodine to produce essential ...

For most people with uterine cancer, treatment is effective, but in some people, uterine cancer can recur either in the uterus or in another part of the body. Share on Pinterest Getty Images/FG Trade ...

Melanoma is a type of skin cancer that develops in the cells that give skin its color. A dermatologist can remove and treat melanoma. However, it can return after treatment, becoming recurrent ...